These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9667062)

  • 1. Psychological features of acromegaly.
    Furman K; Ezzat S
    Psychother Psychosom; 1998; 67(3):147-53. PubMed ID: 9667062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quality of life in acromegaly.
    Pantanetti P; Sonino N; Arnaldi G; Boscaro M
    J Endocrinol Invest; 2003; 26(8 Suppl):35-8. PubMed ID: 15233210
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality of life in patients with a pituitary adenoma.
    Johnson MD; Woodburn CJ; Vance ML
    Pituitary; 2003 Sep; 6(2):81-7. PubMed ID: 14703017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.
    Yedinak CG; Fleseriu M
    Endocrine; 2014 Aug; 46(3):585-93. PubMed ID: 24282035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception of health and cognitive dysfunction in acromegaly patients.
    Crespo I; Webb SM
    Endocrine; 2014 Aug; 46(3):365-7. PubMed ID: 24664361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acromegaly: recognition of a rare disease in psychiatric practice].
    de Kort AJ; Postulart D; Wetzer GA; Roerink SH
    Tijdschr Psychiatr; 2016; 58(11):794-802. PubMed ID: 27868174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of personality in patients with pituitary adenomas.
    Sablowski N; Pawlik K; Lüdecke DK; Herrmann HD
    Acta Neurochir (Wien); 1986; 83(1-2):8-11. PubMed ID: 3799254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.
    Matta MP; Couture E; Cazals L; Vezzosi D; Bennet A; Caron P
    Eur J Endocrinol; 2008 Mar; 158(3):305-10. PubMed ID: 18299462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process.
    Flitsch J; Spitzner S; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2000; 108(7):480-5. PubMed ID: 11083069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls.
    Sievers C; Ising M; Pfister H; Dimopoulou C; Schneider HJ; Roemmler J; Schopohl J; Stalla GK
    Eur J Endocrinol; 2009 Mar; 160(3):367-73. PubMed ID: 19073833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly.
    Tiemensma J; Biermasz NR; van der Mast RC; Wassenaar MJ; Middelkoop HA; Pereira AM; Romijn JA
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E392-402. PubMed ID: 20843947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quality of life and psychological, social and cognitive functioning of patients with acromegaly.
    Szcześniak D; Jawiarczyk-Przybyłowska A; Rymaszewska J
    Adv Clin Exp Med; 2015; 24(1):167-72. PubMed ID: 25923102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
    Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body Image Perception in Acromegaly Is Not Associated with Objective Acromegalic Changes but Depends on Depressive Symptoms.
    Dimopoulou C; Leistner SM; Ising M; Schneider HJ; Schopohl J; Rutz S; Kosilek R; Frohner R; Stalla GK; Sievers C
    Neuroendocrinology; 2017; 105(2):115-122. PubMed ID: 27453978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remission.
    Pereira AM
    Endocrine; 2015 Dec; 50(3):523-5. PubMed ID: 26349939
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas.
    Leistner SM; Klotsche J; Dimopoulou C; Athanasoulia AP; Roemmler-Zehrer J; Pieper L; Schopohl J; Wittchen HU; Stalla GK; Fulda S; Sievers C
    Eur J Endocrinol; 2015 Jun; 172(6):733-43. PubMed ID: 25792374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric changes correlate with poor psychological outcomes in patients with acromegaly.
    Imran SA; Tiemensma J; Kaiser SM; Vallis M; Doucette S; Abidi E; Yip CE; De Tugwell B; Siddiqi F; Clarke DB
    Eur J Endocrinol; 2016 Jan; 174(1):41-50. PubMed ID: 26586838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living with acromegaly.
    Ezzat S
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):753-60. PubMed ID: 1521520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical acromegaly with undetectable growth hormone and hyperprolactinemia.
    Valenta LJ; Elias AN
    J Natl Med Assoc; 1987 May; 79(5):555, 559-60. PubMed ID: 3586051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Apr; 96(4):964-71. PubMed ID: 21209028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.